The global CDMO will create around 80 jobs as its expands Clinical Services facility and develops Diagnostics and Clinical Technologies operations
Almac will invest US$5.2 milion at its facility in Durham, North Carolina, US
As part of its celebrations to mark 20 years in North America, Almac Group has announced a $5.2 million investment at its Durham, North Carolina plant.
Almac employs around 1,600 people across six facilities in the US and expects to create around 80 new jobs as part of the expansion.
The investment will support expansion of the firm's Clinical Services facility as well as the development of its Diagnostics and Clinical Technologies operations.
'This latest investment and increase in capacity at our Durham facility is a sign of our continuing commitment to offer market driven solutions to our client base,' said Donna Christopher, Global VP Operations, Almac Clinical Services.
'We are delighted to mark our 20th year in the US with such a significant announcement – once again reinforcing our dedication to global expansion.'
Almac first established a presence in the US in 1996 with the opening of its clinical trial operations in Audubon, Pennsylvania.
By 2000, the firm had expanded its North American presence into North Carolina through the acquisition of Applied Clinical Concepts Inc (ACCI) and Duke Clinical Research Institute Pharmacy (DCRIP), which merged to form Clinical Trial Services based in the Research Triangle Park, Durham.
In recent years, Almac has also announced expansions in Asia, acquisitions in the UK and Ireland.